S.Amdt. 142

SA 142. Ms. WARREN (for herself and Mr. Casey) submitted an amendment
intended to be proposed by her to the concurrent resolution S. Con.
Res. 3, setting forth the congressional budget for the United States
Government for fiscal year 2017 and setting forth the appropriate
budgetary levels for fiscal years 2018 through 2026; which was ordered
to lie on the table; as follows:

At the end of title III, add the following:

SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO PROVIDING
FUNDING TO NIH AND FDA TO SUPPORT BIOMEDICAL
INNOVATION RESEARCH.

The Chairman of the Committee on the Budget of the Senate
may revise the allocations of a committee or committees,
aggregates, and other appropriate levels in this resolution
for one or more bills, joint resolutions, amendments,
amendments between the Houses, motions, or conference reports
relating to establishing a Biomedical Innovation Fund that
will support $5,000,000,000 in annual supplementary funds to
the National Institutes of Health and the Food and Drug
Administration to support biomedical innovation research by
the amounts provided in such legislation for those purposes,
provided that such legislation would not increase the deficit
over either the period of the total of fiscal years 2017
through 2021 or the period of the total of fiscal years 2017
through 2026.
______